This survey demonstrates variation in the practical aspects and implementation of 177Lu-DOTATATE therapy in the UK. Variability in behavioural restrictions highlights the need for clear national guidance on performing risk assessments for PRRT, to ensure a consistent patient experience. Free-text responses, particularly those relating to administration methods and incident learning, demonstrate the range of experiences across centres and the potential value of shared learning.
Houghton et al. (Tue,) studied this question.